AI 'Scientists' Screened 50,000 Clinical Trials in a Week at a Stanford Virtual Biotech

A Stanford-linked virtual biotech with an AI chief scientist reportedly ran 37,000 AI agents across 50,000 clinical trials, surfacing patterns toward real drug candidates.

A Stanford-linked virtual biotech company deployed 37,000 AI "scientists" to analyze 50,000 clinical trials in a single week, with an AI serving as chief scientist, according to @ShinkaIoT. The described output is pattern identification leading toward real drug candidates, with the claim that some have drawn pharma validation.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede. Mauris et orci. Aenean nec lorem. In porttitor. Donec laoreet nonummy augue. Suspendisse dui purus, scelerisque at, vulputate vitae, pretium mattis, nunc. Mauris eget neque at sem venenatis eleifend. Ut nonummy. Fusce aliquet pede non pede. Suspendisse dapibus lorem pellentesque magna integer malesuada.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief